APOE and Alzheimer disease: Some recent studies on the APP/PS1 rodent AD models demonstrated a decrease in glymphatic transportation [36] as well as intraneuronal Apolipoprotein E (ApoE, a lipid transporter within the brain) and Aβ accretion [37].